BetterLife Pharma Statistics

Total Valuation

BetterLife Pharma has a market cap or net worth of CAD 16.57 million. The enterprise value is 21.14 million.

Market Cap	16.57M
Enterprise Value	21.14M

Important Dates

The next estimated earnings date is Friday, May 30, 2025.

Earnings Date	May 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+16.76%
Shares Change (QoQ)	+21.84%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	92.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.17
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.05

Current Ratio	0.05
Quick Ratio	0.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-11.85

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-772.02%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	86.13%
Revenue Per Employee	n/a
Profits Per Employee	-583,878
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +62.50% in the last 52 weeks. The beta is 1.46, so BetterLife Pharma's price volatility has been higher than the market average.

Beta (5Y)	1.46
52-Week Price Change	+62.50%
50-Day Moving Average	0.11
200-Day Moving Average	0.12
Relative Strength Index (RSI)	56.12
Average Volume (20 Days)	114,460

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.13

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-4.82M
Pretax Income	-3.55M
Net Income	-4.09M
EBITDA	n/a
EBIT	-4.82M
Earnings Per Share (EPS)	-0.03

Full Income Statement

Balance Sheet

The company has 18,673 in cash and 1.09 million in debt, giving a net cash position of -1.07 million.

Cash & Cash Equivalents	18,673
Total Debt	1.09M
Net Cash	-1.07M
Net Cash Per Share	n/a
Equity (Book Value)	-6.65M
Book Value Per Share	-0.08
Working Capital	-5.60M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-2.26M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BetterLife Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.76%
Shareholder Yield	-16.76%
Earnings Yield	-24.67%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a